Thromboembolism in Obstetrics

HMSO. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991–1993. London: HMSO, 1996

Beyth RJ Cohen AM Landefeld CS . Long-term outcomes of deep-vein thrombosis. Arch Intern Med. 1995; 155: 1031–1037

Bonnar J McNicol GP Douglas AS . The blood coagulation and fibrinolytic systems in the newborn and the mother at birth. J Obstet Gynaecol Br Commonw 1971; 78: 355–360

Schulman S Rhedin AS Lindmarker P A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995; 332: 1661–1665

Dahlback B. Are we ready for factor V Leiden screening? Lancet 1996; 347: 1346–1347

Svensson PJ Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994; 330: 517–522

Preston FE Rosendaal FR Walker ID Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913–916

Ginsberg JS Wells PS Brill Edwards P Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685–3691

Paull J. A prospective study of dextran-induced anaphylactoid reactions in 5745 patients. Anaesth Intensive Care 1987; 15: 163–167

Dahlman T Lindvall N Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum. Br J Obstet Gynaecol 1990; 97: 221–228

Simpson FG Robinson PJ Bark M Losowsky MS . Prospective study of thrombophlebitis and ‘pseudothrombophlebitis’. Lancet 1980; 1: 331–333

Lensing AW Prandoni P Brandjes D Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med. 1989; 320: 342–345

Laros RK Jr Alger LS . Thromboembolism and pregnancy. Clin Obstet Gynecol 1979; 22: 871–878

Barbour LA Smith JM Marlar RA . Heparin levels to guide thromboembolism prophylaxis during pregnancy. Am J Obstet Gynecol 1995; 173: 1869–1873

Rizzoli R Bonjour JP . Pregnancy-associated osteoporosis. Lancet 1996; 347: 1274–1276

Douketis JD Ginsberg JS Burrows RF Duku EK Webber CE Edwards P. Brill The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study. Thromb Haemost 1996; 75: 254–257

Forestier F Daffos F Pavlovsky M. Capella Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound. Thromb Res. 1984; 34: 557–560

Hull RD Raskob GE Pineo GF Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med. 1992; 326: 975–982

Eichinger S Kyrle PA Brenner B Thrombocytopenia associated with low-molecular-weight heparin. Lancet 1991; 337: 1425–1426

Pettifor JM Benson R. Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 1975; 86: 459–462